CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 5th Annual Piper Jaffray Europe Conference on Wednesday, June 23, 2010 at 10:30 a.m. BST (5:30 a.m. ET) at the Andaz Liver Pool Street London Hotel.
